Trans-Pacific Aerospace Company Inc (OTCMKTS:TPAC) reported that it is initiating full production operations at its facilities based in Dongguan, China. The two experts, Dr. Clairmont Griffith and Dr. Daniel Desta, who have been involved in company for some time, will financially support the operations in China. They will provide financing which will enable company to create TPAC China.
Dr. Griffith and Dr. Desta are owners and founders of TPAC China, along with Trans-Pacific Aerospace and Bill McKay. TPAC China will look after all production operations in China. In addition to bearings, the company intends to venture into other product lines pertaining to aerospace.
The expert comments
Dr. Griffith, the co-founder of Tran-Pacific and member of the Board said that the company has three phases for success. He explained all the three phases. The first phase was the approval of products by NAVAIR followed by funding in the second phase to support full-scale production. The third phase involves getting purchase orders.
The second phase of funding enables company to achieve its goal of full-scale production, which in turn will help company to obtain purchase orders and manufacture large volumes of parts. The company is presently reviewing products for prospective long-term orders. Dr. Griffith said that they have an outstanding product and an expert team that will lead company to rapid growth and development in the aerospace industry.
The commitment
Dr. Desta said that they have been extremely supportive of company both financially and from an advisory perspective. Bill McKay, the CEO of Trans-Pacific, said that they are delighted to be associated with the two experts. They have played an important role in the success of TPAC.
In last trading session, the stock price of Trans-Pacific Aerospace Company Inc (OTCMKTS:TPAC) surged more than 16% to close the trading session at $0.00070. The gains came at a share volume of 108.95 million compared to average share volume of 246.29 million.
